19-38565283-GTGCGGCGGC-GTGCGGCGGCTGCGGCGGC

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM4

The NM_000540.3(RYR1):​c.12960_12968dupGCGGCGGCT​(p.Leu4323_Thr4324insArgArgLeu) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,005,090 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L4323L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000082 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000036 ( 0 hom. )

Consequence

RYR1
NM_000540.3 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:7O:1

Conservation

PhyloP100: 1.66

Publications

1 publications found
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
RYR1 Gene-Disease associations (from GenCC):
  • malignant hyperthermia, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Ambry Genetics
  • congenital multicore myopathy with external ophthalmoplegia
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • RYR1-related myopathy
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: ClinGen
  • central core myopathy
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • King-Denborough syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant hyperthermia of anesthesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • benign Samaritan congenital myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital myopathy with myasthenic-like onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_000540.3.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR1NM_000540.3 linkc.12960_12968dupGCGGCGGCT p.Leu4323_Thr4324insArgArgLeu disruptive_inframe_insertion Exon 91 of 106 ENST00000359596.8 NP_000531.2 P21817-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR1ENST00000359596.8 linkc.12960_12968dupGCGGCGGCT p.Leu4323_Thr4324insArgArgLeu disruptive_inframe_insertion Exon 91 of 106 5 NM_000540.3 ENSP00000352608.2 P21817-1

Frequencies

GnomAD3 genomes
AF:
0.0000818
AC:
12
AN:
146752
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000489
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000271
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000390
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000606
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000361
AC:
31
AN:
858338
Hom.:
0
Cov.:
30
AF XY:
0.0000226
AC XY:
9
AN XY:
398990
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
16264
American (AMR)
AF:
0.00
AC:
0
AN:
1922
Ashkenazi Jewish (ASJ)
AF:
0.000176
AC:
1
AN:
5692
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4512
South Asian (SAS)
AF:
0.0000570
AC:
1
AN:
17536
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
3196
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1724
European-Non Finnish (NFE)
AF:
0.0000334
AC:
26
AN:
778712
Other (OTH)
AF:
0.000104
AC:
3
AN:
28780
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000818
AC:
12
AN:
146752
Hom.:
0
Cov.:
32
AF XY:
0.0000840
AC XY:
6
AN XY:
71388
show subpopulations
African (AFR)
AF:
0.0000489
AC:
2
AN:
40910
American (AMR)
AF:
0.000271
AC:
4
AN:
14768
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3392
East Asian (EAS)
AF:
0.000390
AC:
2
AN:
5134
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8512
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.0000606
AC:
4
AN:
65964
Other (OTH)
AF:
0.00
AC:
0
AN:
2022
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.408
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:5Other:1
-
RYR1 database
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Mar 01, 2017
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 15, 2022
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The RYR1 c.12960_12968dup (p.Arg4321_Leu4323dup) variant results in a duplication of three amino acids in a non-repetitive region, arginine, arginine and leucine, at amino acid positions 4321, 4322 and 4323, respectively. This is an inframe event and is therefore predicted to preserve the reading frame. This variant is also referred to as c.12959_12967dup (p.Arg4320_Leu4322dup). The p.Arg4321_Leu4323dup has been reported in a heterozygous state in two individuals, an adult with elevated CK and an abnormal calcium-induced calcium release (CICR) test, and a child who expired following prolonged exposure to high temperature. However, neither were definitively diagnosed with malignant hyperthermia susceptibility at the time of reporting (PMID: 16732084; PMID: 19223216). The highest frequency of this allele in the Genome Aggregation Database is 0.000390 in the East Asian population (version 3.1.2). The p.Arg4321_Leu4323dup variant is in the CaM binding domain 3 (CaMBD3) of the RyR1 protein and isothermal titration calorimetry demonstrates that the variant results in altered binding between RyR1 and CaM, however the clinical implications of this finding are unclear (PMID: 24447242). Based on the available evidence, the c.12960_12968dup variant is classified as a variant of uncertain significance for malignant hyperthermia susceptibility. -

Aug 28, 2024
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 22, 2020
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 16, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported (as c.12959_12967dup) in an individual with elevated creatine kinase levels and malignant hyperthermia susceptibility (PMID: 16732084); Identified with a second variant in an individual that died after being exposed to extreme heat for a significant amount of time (PMID: 19223216); In-frame insertion of 3 amino acids in a non-repeat region; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23476141, 19223216, 16732084) -

RYR1-related disorder Uncertain:1
Nov 07, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.12960_12968dup, results in the insertion of 3 amino acid(s) of the RYR1 protein (p.Arg4321_Leu4323dup), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has been observed in individual(s) with increased serum creatine kinase and malignant hyperthermia susceptibility (PMID: 16732084). This variant is also known as c.12959_12967dup, L4320_R4322dup, duplication of L4319 to R4321. ClinVar contains an entry for this variant (Variation ID: 133044). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects RYR1 function (PMID: 24447242). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Congenital myopathy with fiber type disproportion;C1840365:King Denborough syndrome;C1850674:Congenital multicore myopathy with external ophthalmoplegia;C2930980:Malignant hyperthermia, susceptibility to, 1;C5830701:Central core myopathy Uncertain:1
Aug 23, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.7
Mutation Taster
=36/64
disease causing

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs193922846; hg19: chr19-39055923; API